金力永磁(300748.SZ):擬新增發不超2%H股
格隆匯1月28日丨金力永磁(300748.SZ)公佈,公司於2024年1月26日召開第三屆董事會第二十四次會議及第三屆監事會第二十一次會議,審議通過《關於公司新增發行H股方案的議案》,公司擬新增發行境外上市外資股(H股)並在香港聯合交易所有限公司主板掛牌上市(稱“本次H股發行”),根據相關法律、法規規定並結合本公司財務狀況和投資計劃,本次增發H股發行的H股不超過董事會召開日公司總股本比例的2%,即不超過26,895,424股(含本數)。其中,江西瑞德擬認購比例不超過董事會召開日公司總股本比例的1.5%,即不超過20,171,568股(含本數),剩餘部分由其他合格投資者認購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.